top of page
DE.jpg

IN THE STATES

DELAWARE

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. This map illustrates jobs and  economic impact data, clinical trial data, and vendor/supplier data from 16 biopharmaceutical companies regarding their business relationships with vendors and the total expenditures paid to vendors in Delaware.

DE.png

Economic
Output

$3.9B

Direct Jobs Supported by the Industry

4,038

Total Jobs Supported

14,838

State Total Vendor Relationships

584

State Total Vendor Spending

$214,172,362

Total Clinical
Trials

68

Dollar Amount Invested

$7.3M

Clinical Trial Participants

770

Total Economic Impact

$18.1M

bottom of page